Treatments for nervous disorders
US6586427B2 · kind B2 · utility
5Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2001 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Aug 13, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5375
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.